Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imran H Yusuf

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|March 19, 2013
Opaque intraocular lens implantationImran H Yusuf, Ck Patel
The New England Journal of Medicine|November 12, 2021
Retinopathy in Malignant HypertensionFederica Poli, Imran H Yusuf
JAMA Ophthalmology|August 18, 2022
Thinking Outside the Circle-The Potential Value of Ultra-Widefield ImagingImran H Yusuf, Andrew J Lotery
BMJ Case Reports|March 24, 2012
A sticky sight: cyanoacrylate 'superglue' injuries of the eyeImran H Yusuf, C K Patel
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 24, 2018
Requirement for retinal screening in patients taking hydroxychloroquine and chloroquineAndrew J Lotery, Imran H Yusuf
Cold Spring Harbor Perspectives in Medicine|June 5, 2023
Choroideremia: Toward Regulatory Approval of Retinal Gene TherapyImran H Yusuf, Robert E MacLaren
Journal of Medical Case Reports|May 27, 2016
Iridoschisis and keratoconus in a patient with severe allergic eye disease and compulsive eye rubbing: a case reportImran H Yusuf, John F Salmon
Eye (London, England)|April 21, 2023
Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE studyImran H Yusuf, Christin Henein, Sobha Sivaprasad
Eye (London, England)|February 4, 2023
Infographic: Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR studyImran H Yusuf, Christin Henein, Sobha Sivaprasad
Eye (London, England)|April 21, 2023
Infographic: Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months: the VICI studyImran H Yusuf, Christin Henein, Sobha Sivaprasad
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Clinical Ophthalmology (Auckland, N.Z.)|March 19, 2013
Opaque intraocular lens implantationImran H Yusuf, Ck Patel
The New England Journal of Medicine|November 12, 2021
Retinopathy in Malignant HypertensionFederica Poli, Imran H Yusuf
JAMA Ophthalmology|August 18, 2022
Thinking Outside the Circle-The Potential Value of Ultra-Widefield ImagingImran H Yusuf, Andrew J Lotery
BMJ Case Reports|March 24, 2012
A sticky sight: cyanoacrylate 'superglue' injuries of the eyeImran H Yusuf, C K Patel
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 24, 2018
Requirement for retinal screening in patients taking hydroxychloroquine and chloroquineAndrew J Lotery, Imran H Yusuf
Cold Spring Harbor Perspectives in Medicine|June 5, 2023
Choroideremia: Toward Regulatory Approval of Retinal Gene TherapyImran H Yusuf, Robert E MacLaren
Journal of Medical Case Reports|May 27, 2016
Iridoschisis and keratoconus in a patient with severe allergic eye disease and compulsive eye rubbing: a case reportImran H Yusuf, John F Salmon
Eye (London, England)|April 21, 2023
Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE studyImran H Yusuf, Christin Henein, Sobha Sivaprasad
Eye (London, England)|February 4, 2023
Infographic: Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR studyImran H Yusuf, Christin Henein, Sobha Sivaprasad
Eye (London, England)|April 21, 2023
Infographic: Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months: the VICI studyImran H Yusuf, Christin Henein, Sobha Sivaprasad
Pageof 9